Awardee OrganizationSTATE UNIVERSITY OF NEW YORK AT BUFFALO
Description
Abstract Text
The ultimate research goal of this lab is to decipher the gene regulatory network that directs the development of
various types of neurons in the mouse arcuate nucleus of the hypothalamus (ARC). Despite the physiological
significance of many ARC neurons, the developmental gene regulatory programs for ARC neurons remain poorly
understood. This lab has been pioneering this emerging area of studies by successfully combining mouse
genetics and genome-wide studies. Notably, a close developmental link has been discovered among different
types of ARC neurons. These intertwined developmental pathways are likely crucial to ensure the balanced
production of different ARC neurons during embryogenesis, enabling a highly coordinated regulation of various
homeostatic processes in later postnatal life, such as integration of feeding, reproduction, and growth.
Key preliminary results in this grant include: i) Single cell RNA-seq (scRNA-seq) analyses reveal eight TFs
enriched in developing growth hormone-releasing hormone (GHRH)-neurons in the ARC, which control linear
growth; Prox1, Gsx1, Egr1, Foxp2, Pbx3, St18, Dlx1 and Dlx2. Notably, Dlx1/2, Foxp2 and Gsx1 have been
shown to be important for the development of GHRH-neurons, indicating that the scRNA-seq approach is highly
useful to identify TFs acting on neuronal lineage development. ii) GHRH-specific inactivation of Prox1 leads to
dwarfism and reduced Ghrh expression in mice. iii) Further, ChIP-seq data for Dlx1 provides various new insights
into the mechanism by which Dlx1 controls GHRH-neuronal development. Together, these results led to the
central hypothesis Dlx1/2 and Prox1 play vital roles in acquiring GHRH-neuronal fate over other related
ARC neuronal lineages in part by coordinating the expression of downstream TFs. This hypothesis will be
tested in the two specific aims using an ensemble of biochemical and cellular methods, mouse genetics and
genome-wide approaches. Completion of this innovative study will radically improve the understanding of how
common progenitors are guided to gain a specific ARC lineage identity over other related cell fates, providing a
critical mechanism contributing to the balanced production of diverse ARC neuronal types during development.
Public Health Relevance Statement
Understanding of the central regulation of growth and energy homeostasis is important to fight against dwarfism
and various metabolic diseases. Despite great advances in physiological understanding of the hypothalamic
neurons that control these processes, how they are formed during development is ill-defined, and this critical
issue will be dissected in this proposal.
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
038633251
UEI
LMCJKRFW5R81
Project Start Date
01-August-2021
Project End Date
31-July-2025
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$531,437
Direct Costs
$333,190
Indirect Costs
$198,247
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Neurological Disorders and Stroke
$531,437
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS118748-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS118748-04
Patents
No Patents information available for 5R01NS118748-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS118748-04
Clinical Studies
No Clinical Studies information available for 5R01NS118748-04
News and More
Related News Releases
No news release information available for 5R01NS118748-04
History
No Historical information available for 5R01NS118748-04
Similar Projects
No Similar Projects information available for 5R01NS118748-04